BMP vs CMP: Key Differences
A Basic Metabolic Panel (BMP) contains 8 tests measuring electrolytes, kidney function, and glucose, while a Comprehensive Metabolic Panel (CMP) contains these same 8 tests plus 6 additional liver function tests (LFTs), making it a 14-test panel.
Components Breakdown
BMP includes (8 tests):
- Sodium, potassium, chloride, bicarbonate (electrolytes)
- Blood urea nitrogen (BUN) and creatinine (kidney function)
- Glucose
- Calcium 1
CMP adds to the BMP (6 additional tests):
- Alanine aminotransferase (ALT)
- Aspartate aminotransferase (AST)
- Alkaline phosphatase (ALP)
- Total bilirubin
- Total protein
- Albumin 1
Clinical Application Guidance
When to order a BMP:
- Routine monitoring of electrolytes and kidney function 1
- Hypertension management and medication titration 1
- Patients without clinical indicators for liver assessment 2
- Follow-up within 2-4 weeks after starting medications affecting electrolytes or kidney function 1
When to order a CMP:
- Initial workup for malignancies (e.g., Waldenström macroglobulinemia, kidney cancer) 1
- Systemic autoimmune rheumatic diseases requiring immunosuppressive therapy 1
- Suspected liver disease, heart disease, jaundice, or hepatomegaly 2
- Patients with right upper quadrant pain, history of liver disorder, bleeding disorder, or ascites 2
- Baseline assessment for medications with hepatotoxicity risk 1
Cost-Effectiveness Considerations
The cost difference between BMP and CMP is approximately $21 per test 2. Research demonstrates that ordering CMPs without specific clinical indications for liver function assessment results in:
- Increased unnecessary testing volumes (>3-fold increase in some studies) 3
- Low yield of clinically significant abnormalities in patients without risk factors 2
- Potential annual savings of $7,125 per emergency department when BMPs are appropriately substituted for CMPs in patients without the 12 clinical variables listed above 2
Common Pitfall to Avoid
Do not automatically order a CMP when only electrolyte and kidney function monitoring is needed. The false-negative rate for missing significant liver abnormalities when using clinical criteria to determine CMP necessity is only 16%, and most missed abnormalities are marginal and require no intervention 2. Conversely, implementation of routine CMP testing dramatically increases calcium testing volumes without changing the rate of calcium-related diagnoses 3.